I In nt tr ro od du uc ct ti io on n. . The contractile effect of angiotensin II via AT 1 receptors on the kidney arterioles is a crucial element in the kidney microcirculation. Angiotensin II also plays a role as an inhibitor via the AT 1 receptors in the renin granulation of the arterioles. We have previously demonstrated that the AT 1 receptors are downregulated in the renin-positive smooth muscle cells (SMCs) in contrast to renin-negative SMCs. In this study, we estimated the numbers of the AT 1 receptor sub-types separately in the afferent and efferent arterioles and the renin-positive and renin-negative SMCs. M Me et th ho od ds s. . The immunohistochemical signals of the AT 1 -A and AT 1 -B receptors were counted by stereological methods. 1 R Re es su ul lt ts s. . The number of AT 1 -B receptors in the efferent arterioles (expressed in signals/µm 3 ; mean (CV): 0.32 (0.33)) was significantly higher (78%; p<0.05) as compared with the number in the afferent arterioles (0.18 (0.11)). No differences were found in the AT 1 -A receptors. In a number of AT 1 -A receptors, significant differences (p<0.01) were detected between the afferent arteriolar renin-positive SMCs (0.13 (0.36)) and the number in renin-negative SMCs (0.25 (0.34)). The AT 1 -B receptors did not display any differences. C Co on nc cl lu us si io on ns s. . These results indicate that the AT 1 receptor sub-types are regulated independently in the SMCs of the normal kidney arterioles.
Introduction
The microcirculation of the kidney is controlled by the renin-angiotensin system. Angiotensin II exerts a contractile effect on the afferent and efferent arterioles. This contractile effect can be antagonised by an angiotensin II AT 1 receptor blocker. The contraction produced by angiotensin II on the efferent arterioles results in an opposite effect on the afferent arterioles as concerns the glomerular blood flow and/or glomerular filtration pressure, and hence on the glomerular filtration rate (GFR). 2 Differences exist not only between the results relating to the GFR, but also regarding the degree of contraction between the afferent and efferent arterioles. 3 In experiments on the angiotensin II AT 1 -A receptor knockout rat, the vasoconstriction of angiotensin II on the afferent arterioles was mediated by both AT 1 -A and AT 1 -B, whereas on the efferent arterioles it was mediated only by the AT 1 -A receptors. 4, 5 Estimation of the numbers of the sub-types of the angiotensin II AT 1 receptor in the normal rat could clarify the physiological situation from the aspect of the possible differences in the contractile effect of angiotensin II on various arterioles.
The renin produced by smooth muscle cells (SMCs) in the afferent arterioles is a primary source of the circulating and intrarenal renin. 3 The renin granulation of the renal arterioles is controlled by the renin-angiotensin system. Angiotensin II antagonises the transformation of the SMCs to renin-granulated cells. Antagonism of the effect of the angiotensin II by using the angiotensin II AT 1 receptor blockers leads to an increase in the renin-granulated area of the afferent arterioles. [6] [7] [8] The AT 1 receptors, key molecules in this process, are down-regulated in the renin-positive SMCs versus the non-reningranulated SMCs. 9 The AT 1 receptors have two isoforms: the AT 1 -A and AT 1 -B; accordingly, the question arises as to which of the sub-types plays a role in the renin granulation of the SMCs. In this study, therefore, the numbers of the AT 1 -A and AT 1 -B receptors were estimated in reningranulated versus non-renin-granulated SMCs in afferent arterioles of the normal rat kidney.
Materials and methods

Animals and tissue preparation
A total of five female adult Wistar rats (180-200 g) was used to determine the number of AT 1 -A and AT 1 -B receptors in the afferent and efferent arterioles. The studies were approved by the Danish Animal Inspectorate. The animals were anaesthetised with Nembutal (25 mg/kg i.p.). The right kidney was removed immediately from three rats, and the left kidney from two rats. The kidneys were quickly cut into 2-mm slices and small pieces of kidney cortex were randomly sampled and fixed in 4% formalin in PBS (pH=7.4) for three hours. After overnight cryoprotection with 30% sucrose in PBS (pH=7.4), the 10-µm frozen serial sections were placed on Superfrost + glass slides. The sections were kept in a refrigerator at 4 o C for one to three days until the immunohistochemical procedure.
For staining of the angiotensin II AT 1 receptor sub-types and embedding of the tissue for sectioning, the same protocol was used as described earlier. 1
Immunohistochemistry
The sections on the glass slides were washed in PBS (pH=7.4) for 10 minutes, and then incubated in normal goat serum 1:100 (EMS, USA) in PBS (pH=7.4) for 20 minutes. The primary antibody against the AT 1 -A or AT 1 -B receptor of angiotensin II (rabbit polyclonal, Advance Targeting Systems, San Diego, USA) was diluted in 1:50 PBS (pH=7.4) and left overnight at 4 o C in a wetting chamber. The sections were subsequently washed three times in PBS (pH=7.4), for 5 minutes each time. 0.8-nm gold-conjugated goat-anti-rabbit IgG (Aurion Immunogold; EMS) was diluted in 1:100 PBS (pH=7.4), allowed to stand for 2 hours, and washed three times in PBS (pH=7.4) for 5 minutes. The sections were fixed with 3% glutaraldehyde in PBS (pH=7.4) and washed with distilled water for 5 minutes, followed by silver enhancement with Danscher solution (Aurion R-gent SE-EM; EMS) for 75 minutes at 25 o C, resulting in a particle size around 30 nm. Finally, they were washed three times with distilled water, for 5 minutes each time. The antibodies did not cross-react with angiotensin II AT 2 receptors and angiotensin II AT 1 -A or angiotensin II AT 1 -B sub-types. 10
Embedding and sectioning
The immunostained serial sections on the glass slides were dehydrated with a standard series of ethanol and acetone and infiltrated for 10 minutes with epoxy resin (TAAB 812). The sections were capped with plastic capsules filled with clean resin. The semi-thin (0.4-µm) and thin (70±5-nm; mean±SD) sections were prepared with an Ultracut S (Leica) ultramicrotome. The thin sections were stained with uranyl acetate and lead citrate.
Stereology
For sampling and estimation of the numbers of the angiotensin II AT 1 receptor sub-types, the same protocol was used as described earlier. 9 The afferent arterioles were defined as preglomerular arterioles from the juxtaglomerular apparatus to the first arteriolar branch. The efferent arterioles were defined as postglomerular arterioles from the juxtaglomerular apparatus to the capillary. Each arteriole was followed on a series of semithin sections, and profiles appearing from the same arteriole were identified. 11, 12 From all the mapped profiles of the arterioles, micrographs were prepared for microscopy. The montages were produced automatically from 15 to 25 images by a special Analysis software 3.1 module (Soft Image System GmbH, Münster, Germany) on a Philips CM10 electron microscope (FEI, Eindhoven, Netherlands) equipped with a Kodak Megaplus 1.6i camera. The original magnification of the transmission electron microscopy micrographs (single or montage) was ×13,500. On each afferent and efferent arteriolar profile, the enhanced gold particles were counted only on the surface of the smooth muscle and the reningranulated cells. The intracellular signals were excluded. The areas of these cells on the profiles were measured by means of a point grid where the test point area was 2,000 nm × 2,000 nm.
The densities of the number of AT 1 -A or AT 1 -B receptor molecules in the arteriolar SMCs were calculated by using a modified counting rule:
where t is the thickness of the Epon sections, 70 nm; ΣAT 1 is the total number of AT 1 -A or AT 1 -B receptor molecules on the SMC surface; (a/p) is the area per point of the counting grid; and ΣP(SMC, art) is the total number of points appearing on the arteriolar SMCs. More details may be found in our recent article. 1
Statistics
For the comparison of differences between two groups, the Mann-Whitney test was used.
Results
In this study, the locations of the AT 1 receptors were similar to data in the literature. [13] [14] [15] [16] The combined number of angiotensin II AT 1 -A and AT 1 -B sub-types was equal to the total number of AT 1 receptors and was significantly higher in the efferent arterioles than in the afferent arterioles (table 1) . In normal arterioles, the number of angiotensin II AT 1 -B receptors was significantly higher in efferent arterioles compared to afferent arterioles, while the number of AT 1 -A receptors was the same in both (table 1).
In renin-granulated SMCs, the number of AT 1 -A receptors was significantly lower compared to renin-negative SMCs in normal rats. The AT 1 -B receptors were present in similar numbers in renin-positive and renin-negative SMCs (table 2) .
Discussion
The contractile effects of angiotensin II on the renal arterioles are crucial features in the basal renal arteriolar tone. The AT 1 receptor blockers inhibit most of the contractile effects of angiotensin II on the afferent and efferent arterioles. 17, 18 These contractile effects are not homogeneous on the afferent and efferent arterioles. Some authors consider that angiotensin II causes more contraction in the postglomerular arterioles than in the preglomerular arterioles. However, the exact mechanism by which angiotensin II regulates the GFR remains to be clarified. 3 Angiotensin II also influences the renin granulation of the afferent arterioles via the AT 1 receptors. 6, 8 On the surface of the renin-positive SMCs in normal rat afferent arterioles, the angiotensin II AT 1 receptors are down-regulated as compared with the renin-negative SMCs. 9 The purpose of the present study was to acquire information on the up-and down-regulation of angiotensin II AT 1 -A and AT 1 -B receptor sub-types on the surface of the SMCs in the arterioles. A stereological method was used to estimate the number of molecules labelled by immunohistochemistry at the transmission electron microscopy level. 1 Immuno-electron microscopy can furnish exact quantitative data on the immunohistochemical signals at a cellular level, with the highest resolution. 1
The number of AT 1 receptor sub-types in afferent and efferent arterioles
We have previously demonstrated that the numbers of AT 1 receptors on the SMCs did not differ significantly between the afferent and efferent arterioles. 9 The estimated number of AT 1 receptors was 27.5% higher on the efferent arterioles than on the afferent arterioles, but the difference was not significant.
In the present study, the total number of AT 1 -A and AT 1 -B sub-types was significantly higher, by 38.0% (p<0.05) in the efferent arterioles than in the afferent arterioles (table 1) . The B sub-type of the AT 1 receptor was up-regulated in the SMCs of normal postglomerular arterioles relative to the preglomerular arterioles (figure 1). In two estimations, the same method was used, but with different primary antibodies. The first result produced by the antibody against the angiotensin II AT 1 receptors (rabbit IgG; Santa Cruz Biotechnology, USA) was confirmed in the estimation of the numbers of the AT 1 -A and AT 1 -B receptor sub-types.
Microvascular functional studies have shown that in the efferent arterioles in AT 1 -A knockout mice only the AT 1 -A receptors are present, whereas in the afferent arterioles both AT 1 -A and AT 1 -B receptors are present. 4, 19 These results based on functional examinations of knockout mice are in contrast with our results obtained by immunohistochemical processing on arterioles. We used Table 1 The relative numbers of angiotensin II AT 1 -A and AT 1 -B receptors in normal kidney afferent and efferent arterioles. Table 2 The relative numbers of angiotensin II AT 1 -A and AT 1 -B receptors in renin-positive and renin-negative SMCs of normal afferent arterioles.
Renin-positive Renin-negative Difference p
Mean (CV) Angiotensin II AT 1 normal rats without any experimental treatment, whereas knockout mice represent an experimental situation, which could be a possible reason for the difference in the two results. The absence of the AT 1 -A receptor gene may change the distribution of the other angiotensin II receptor sub-types.
Certain physiological data indicate that angiotensin II exerts a stronger contractile effect on the postglomerular than on the preglomerular arterioles, but the exact mechanism remains to be clarified. 3 The present study demonstrated that angiotensin II had a higher activity in efferent arteriolar SMCs in normal animals due to the higher number of angiotensin II receptors. This up-regulation of the receptors was selective for the B sub-type of angiotensin II AT 1 receptors, which furnishes the possibility of selective antagonism of a higher sensitivity. The efferent arteriolar contraction results in just the opposite effect on GFR as that caused by the afferent arteriolar contraction. 2 Reduction of the sensitivity of the efferent arterioles to angiotensin II by selective angiotensin II AT 1 -B receptor antagonists could reduce the potential negative effect on the GFR.
The number of AT 1 receptor sub-types in renin-positive and renin-negative SMCs
The number of AT 1 receptors in the renin-granulated cells is significantly lower in the renin-positive than in the renin-negative SMCs of the afferent arterioles. 9 Cyclosporin treatment increases the renin granulation throughout the full length of the afferent arterioles and the mRNA of the AT 1 receptors decreases throughout the whole kidney. 20 The effect of angiotensin II is decreased by treatment with a selective AT 1 receptor or angiotensin-converting enzyme blocker; the level of the mRNA of the renin in the kidney increases in parallel with the renin plasma level and the extent of renin granulation of the afferent arterioles. [6] [7] [8] In AT 1 -A -/-and AT 1 -A -/-AT 1 -B -/-knockout mice, the renin expression is higher, whereas the degree of renin granulation of the SMCs in the afferent arterioles of AT 1 -B -/knockout mice is the same as that in normal mice. 21 Thus, the antagonist effect of angiotensin II on renin granulation is coupled to the AT 1 -A receptor sub-type. The results of this study revealed that in the normal kidney the AT 1 -A receptor molecule was down-regulated in the renin-positive SMCs as compared with the reninnegative SMCs of the afferent arterioles ( figure 2 ). This study confirmed our earlier finding, 9 that the number of AT 1 -A receptors could change on the SMCs in the normal rat. The mechanism controlling the number of the AT 1 -A receptors on the SMCs of the afferent arterioles in normal animals is not known, but our results indicate this mechanism controls the renin granulation of the afferent arterioles in the normal state.
Conclusions
Our results confirmed the physiological data pointing to stronger contractile effects of angiotensin II on the efferent arterioles than on the afferent arterioles, since the up-regulation of the AT 1 -B sub-type may cause an enhanced sensitivity of the efferent arterioles to angiotensin II. The effect of angiotensin II on the renin granulation of the afferent arterioles is mediated via the AT 1 -A receptors despite the low number of these molecules in the renin-granulated SMCs.
These data demonstrated that the AT 1 receptor sub-type can be up-or down-regulated independently in the normal kidney arterioles as required for normal function. This regulation of the AT 1 receptor sub-types in these two different ways could play an important role in governing the arteriolar tone in the normal kidney.
The present results have furnished more details on the effects of angiotensin II on the arterioles, opening up the possibility of specifically antagonising contractile effects on the different arterioles and/or on renin granulation with available selective antagonists against the AT 1 -A and AT 1 -B receptors.
